It’s willing to pay US$44bil for Genentech shares
BASEL: Swiss drugmaker Roche Holding AG offered to acquire all outstanding shares in its US partner Genentech Inc for US$43.7bil in cash to reinforce its position in cancer medicine.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
